Published in N Engl J Med on December 12, 1968
Use and control of cephalosporins. J Clin Pathol (1971) 5.12
Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci. Antimicrob Agents Chemother (1973) 2.78
Acute renal failure associated with combined gentamicin and cephalothin therapy. Br Med J (1973) 2.10
Relative incidence of phlebitis caused by continuous intravenous infusion of cephapirin and cephalothin. Antimicrob Agents Chemother (1972) 1.74
Protective effect of cephalothin against gentamincin-induced nephrotoxicity in rats. Antimicrob Agents Chemother (1976) 1.47
Cephalosporin-aminoglycoside synergism in experimental enterococcal endocarditis. Antimicrob Agents Chemother (1976) 1.21
Studies of cephalothin: aminoglycoside synergism against enterococci. Antimicrob Agents Chemother (1975) 1.18
Use of sodium cephalothin in the management of lung gangrene. Thorax (1971) 0.93
Comparative incidence of phlebitis due to buffered cephalothin, cephapirin, and cefamandole. Antimicrob Agents Chemother (1976) 0.83
Infectious diseases. Annual review of significant publications. Postgrad Med J (1969) 0.75
Septicaemia in the neutropenic patient. Br Med J (1974) 0.75
Cephalosporins in gram-positive infections. Drugs (1987) 0.75
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob Agents Chemother (1997) 7.07
Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med (1993) 6.12
Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med (1986) 5.83
Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet (1994) 5.73
Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms. Antimicrob Agents Chemother (1976) 4.55
Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol (1982) 4.21
Studies of intestinal microflora. II. Microorganisms of the small intestine and their relations to oral and fecal flora. Gastroenterology (1967) 3.71
Studies of intestinal microflora. I. Effects of diet, age, and periodic sampling on numbers of fecal microorganisms in man. Gastroenterology (1967) 3.60
Bactericidal activity and pharmacology of cefazolin. Antimicrob Agents Chemother (1973) 3.26
Infective endocarditis in the antibiotic era. N Engl J Med (1966) 3.06
Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the Steris System 1 processor. Infect Control Hosp Epidemiol (2001) 2.84
Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid. J Infect Dis (1974) 2.81
Nosocomial infection caused by gentamicin-resistant, streptomycin-sensitive Klebsiella. J Infect Dis (1975) 2.66
SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob Agents Chemother (1995) 2.66
Fungal endocarditis: analysis of 24 cases and review of the literature. Medicine (Baltimore) (1975) 2.61
Effect of sulbactam on infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. J Infect Dis (1993) 2.47
Pathoanatomic, pathophysiologic and clinical correlations in endocarditis (first of two parts). N Engl J Med (1974) 2.44
Bactericidal and bacteriostatic action of chloramphenicol against memingeal pathogens. Antimicrob Agents Chemother (1979) 2.43
Infective endocarditis--1973. Prog Cardiovasc Dis (1974) 2.42
Cefamandole: antimicrobial activity in vitro of a new cephalosporin. Antimicrob Agents Chemother (1975) 2.38
Antibiotic combinations: the clinical relevance of synergy and antagonism. Medicine (Baltimore) (1978) 2.33
Penetration of antibiotics into fibrin loci in vivo. I. Comparison of penetration of ampicillin into fibrin clots, abscesses, and "interstitial fluid". J Infect Dis (1974) 2.20
Treatment of infective endocarditis--1973. Prog Cardiovasc Dis (1974) 2.19
Infective endocarditis in the antibiotic era. N Engl J Med (1966) 2.15
Infective endocarditis in the antibiotic era. N Engl J Med (1966) 2.07
Predictability of blood levels of gentamicin in man. J Infect Dis (1975) 2.06
THE EFFECT OF UREA, URETHANE AND OTHER CARBAMATES ON BACTERIAL GROWTH. Science (1945) 2.02
The cephalosporins. Microbiological, chemical, and pharmacological properties and use in chemotherapy of infection. Ann Intern Med (1970) 1.99
Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use. J Infect Dis (1985) 1.92
Cross-resistance of Pseudomonas to gentamicin and tobramycin. Antimicrob Agents Chemother (1972) 1.90
Cervical Chlamydia trachomatis and mycoplasmal infections in pregnancy. Epidemiology and outcomes. JAMA (1983) 1.89
Editorial: Influenza-1918, a revisit? N Engl J Med (1976) 1.89
In-vitro activity of erythromycin against atypical mycobacteria. J Infect Dis (1971) 1.89
Transient bacteremia associated with sigmoidoscopy. N Engl J Med (1973) 1.88
Heat stability and species range of purified staphylococcal alpha-toxin. J Bacteriol (1966) 1.86
Correlation of increased metabolic activity, resistance to infection, enhanced phagocytosis, and inhibition of bacterial growth by macrophages from Listeria- and BCG-infected mice. Infect Immun (1972) 1.85
Role of candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatients. Lancet (1991) 1.82
Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy. Gastroenterology (1968) 1.80
Relation between lipophilicity and pharmacological behavior of minocycline, doxycycline, tetracycline, and oxytetracycline in dogs. Antimicrob Agents Chemother (1975) 1.76
Studies of intestinal microflora. IV. The microflora of ileostomy effluent: a unique microbial ecology. Gastroenterology (1967) 1.76
Type b haemophilus influenzae infections in adults. N Engl J Med (1970) 1.75
Infective endocarditis caused by gram-negative bacteria: a review of the literature, 1945-1977. Prog Cardiovasc Dis (1980) 1.75
Diphtheroid infections of man. Ann Intern Med (1969) 1.69
Pharmacological studies with cefamandole in human volunteers. Antimicrob Agents Chemother (1976) 1.68
Patient survival factors in paranasal sinus mucormycosis. Laryngoscope (1980) 1.68
Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae. Antimicrob Agents Chemother (1994) 1.67
Pharmacologic studies on tobramycin and comparison with gentamicin. J Clin Pharmacol New Drugs (1972) 1.66
In vitro bactericidal effectiveness of four aminoglycoside antibiotics. Antimicrob Agents Chemother (1973) 1.64
Cephanone: in vitro antibacterial activity and pharmacology in normal human volunteers. Antimicrob Agents Chemother (1972) 1.64
Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells. J Immunol (1993) 1.63
Infective endocarditis: past, present and future. J R Coll Physicians Lond (1972) 1.62
Comparison of the antibacterial activities of sisomicin and gentamicin against gram-negative bacteria. Antimicrob Agents Chemother (1975) 1.62
Streptococcus pneumoniae infections and bacteremia in patients with acquired immune deficiency syndrome, with report of a pneumococcal vaccine failure. Am Rev Respir Dis (1984) 1.62
Microbiological and pharmacological behavior of 7-chlorolincomycin. Appl Microbiol (1969) 1.60
Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. J Infect Dis (1989) 1.60
Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin. Antimicrob Agents Chemother (1977) 1.58
The Bacterial Flora of the Human Vagina. Yale J Biol Med (1938) 1.58
Penicillin neurotoxicity. Ann N Y Acad Sci (1967) 1.57
Transient bacteremia associated with barium enema. Arch Intern Med (1975) 1.56
Tobramycin: in vitro antibacterial spectrum of a new aminoglycoside. J Clin Pharmacol New Drugs (1972) 1.55
Penetration of antibiotics into fibrin loci in vivo. II. Comparison of nine antibiotics: effect of dose and degree of protein binding. J Infect Dis (1974) 1.51
Cephapirin: in vitro antibacterial spectrum. Appl Microbiol (1971) 1.50
Protective effect of cephalothin against gentamincin-induced nephrotoxicity in rats. Antimicrob Agents Chemother (1976) 1.47
Thrombocytopenia and symmetrical peripheral gangrene associated with staphylococcal and streptococcal bacteremia. Ann Intern Med (1968) 1.46
Effect of cephalothin on renal cortical concentrations of gentamicin in rats. Antimicrob Agents Chemother (1976) 1.45
Coxsackievirus and adenovirus infection. Association with acute febrile and juvenile rheumatoid arthritis. JAMA (1976) 1.45
Resistance of Staphylococcus aureus to semisynthetic penicillins and cephalothin. J Infect Dis (1977) 1.45
Persistent perplexing pyrexia: some comments on etiology and diagnosis. Med Clin North Am (1970) 1.43
Antibiotic-induced suprainfection. J Infect Dis (1969) 1.42
The Prophylaxis of Experimental Anthrax Infection with Various Hormone Preparations. Yale J Biol Med (1939) 1.41
Central nervous system infections in the elderly. Arch Intern Med (1989) 1.40
Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin. J Antimicrob Chemother (1996) 1.40
Are obstetrical personnel required for intraoperative fetal monitoring during nonobstetric surgery? J Perinatol (1999) 1.40
Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults. Antimicrob Agents Chemother (1982) 1.39
The oath of the healer. JAMA (1991) 1.37
Cephapirin: pharmacology in normal human volunteers. J Clin Pharmacol New Drugs (1972) 1.36
Comparative study of piperacillin, ticarcillin, and carbenicillin pharmacokinetics. Antimicrob Agents Chemother (1980) 1.35
The chemotherapy of viral infections. N Engl J Med (1973) 1.35
Upper respiratory tract carriage of gram-negative enteric bacilli by hospital personnel. JAMA (1970) 1.34
Gentamicin and ampicillin in human bile. J Infect Dis (1971) 1.33
Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes. J Lab Clin Med (1976) 1.31
Lincomycin. Pediatr Clin North Am (1968) 1.30
Neurotoxicity and "massive" intravenous therapy with penicillin. A study of possible predisposing factors. Arch Intern Med (1967) 1.30
Infection due to Actinobacillus actinomycetemcomitans. Am J Clin Pathol (1971) 1.30
Pharmacology of cefazolin in human volunteers. J Clin Pharmacol (1973) 1.29
Pharmacokinetic study of netilmicin. Antimicrob Agents Chemother (1977) 1.28
Intestinal cryptosporidiosis complicated by disseminated cytomegalovirus infection. Gastroenterology (1981) 1.27
Infections caused by microorganisms of the genus Erwinia. Ann Intern Med (1972) 1.27
Clinical and serologic studies of an outbreak of rubella in a vaccinated population. N Engl J Med (1970) 1.26
Single oral dose fluconazole compared with conventional clotrimazole topical therapy of Candida vaginitis. Fluconazole Vaginitis Study Group. Am J Obstet Gynecol (1995) 1.26
Pharmacokinetics of the penicillins in man. Clin Pharmacokinet (1976) 1.25
Maintenance amphotericin B for cryptococcal meningitis in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med (1988) 1.25
Cephalexin: microbiological effects and pharmacologic parameters in man. Clin Pharmacol Ther (1969) 1.25
Studies of intestinal microflora. 3. The microbial flora of human small intestinal mucosa and fluids. Gastroenterology (1967) 1.21
Fluoroquinolone-resistant Streptococcus pneumoniae associated with levofloxacin therapy. J Infect Dis (2001) 1.21
The differentiation of Klebsiella from Aerobacter species by sensitivity to cephalothins and penicillins. Am J Med Sci (1967) 1.21
Pharmacologic studies with cefaclor, a new oral cephalosporin. J Clin Pharmacol (1978) 1.20